Skip to main content

Table 1 Absolute measurements of tumour volume and lung volume as measured by micro-CT, clinical CT, and MRI for all three treatment groups

From: Monitoring treatment effects in lung cancer-bearing mice: clinical CT and clinical MRI compared to micro-CT

 Micro-CTClinical CTClinical MRI
T0T1T0T1T0T1
Cisplatin (n = 10)Lung volume (mL)Mean0.9590.7940.9640.7880.9870.724
SD0.2350.2040.2240.1710.3360.234
Tumour volume (mL)Mean0.6560.4180.5050.2930.7240.401
SD0.2910.1800.2440.1480.3980.225
PBS (n = 12)Lung volume (mL)Mean0.7241.2840.6881.2200.5991.346
SD0.1570.3050.1720.2430.1660.287
Tumour volume (mL)Mean/median0.301*1.0590.2620.8420.2781.153
SD/IQR0.240–0.610**0.3340.1280.2820.1670.343
No treatment (n = 9)Lung volume (mL)Mean1.0871.5971.0801.4970.9881.736
SD0.2380.2890.1980.2690.2300.235
Tumour volume (mL)Mean0.7821.2980.5941.1190.6831.576
SD0.2430.2060.1910.2170.2600.195
  1. CT Computed tomography, IQR Interquartile range, MRI Magnetic resonance imaging, PBS Phosphate-buffered saline, SD Standard deviation, T0 Pretreatment, T1 Posttreatment. In case of non-normally distributed data, median (*) and IQR (**) are given instead and marked